1. Home
  2. ITCI vs ESLT Comparison

ITCI vs ESLT Comparison

Compare ITCI & ESLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • ESLT
  • Stock Information
  • Founded
  • ITCI 2002
  • ESLT 1966
  • Country
  • ITCI United States
  • ESLT Israel
  • Employees
  • ITCI N/A
  • ESLT N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • ESLT Military/Government/Technical
  • Sector
  • ITCI Health Care
  • ESLT Industrials
  • Exchange
  • ITCI Nasdaq
  • ESLT Nasdaq
  • Market Cap
  • ITCI 8.0B
  • ESLT 8.3B
  • IPO Year
  • ITCI N/A
  • ESLT 1996
  • Fundamental
  • Price
  • ITCI $86.40
  • ESLT $228.70
  • Analyst Decision
  • ITCI Strong Buy
  • ESLT
  • Analyst Count
  • ITCI 12
  • ESLT 0
  • Target Price
  • ITCI $97.00
  • ESLT N/A
  • AVG Volume (30 Days)
  • ITCI 459.9K
  • ESLT 23.3K
  • Earning Date
  • ITCI 10-30-2024
  • ESLT 11-26-2024
  • Dividend Yield
  • ITCI N/A
  • ESLT 0.88%
  • EPS Growth
  • ITCI N/A
  • ESLT N/A
  • EPS
  • ITCI N/A
  • ESLT 5.44
  • Revenue
  • ITCI $564,526,000.00
  • ESLT $6,307,469,000.00
  • Revenue This Year
  • ITCI $46.60
  • ESLT $10.97
  • Revenue Next Year
  • ITCI $37.06
  • ESLT $4.93
  • P/E Ratio
  • ITCI N/A
  • ESLT $41.76
  • Revenue Growth
  • ITCI 54.31
  • ESLT 10.60
  • 52 Week Low
  • ITCI $46.10
  • ESLT $175.30
  • 52 Week High
  • ITCI $84.89
  • ESLT $229.70
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 73.36
  • ESLT 78.03
  • Support Level
  • ITCI $75.57
  • ESLT $207.71
  • Resistance Level
  • ITCI $79.46
  • ESLT $229.70
  • Average True Range (ATR)
  • ITCI 2.42
  • ESLT 2.08
  • MACD
  • ITCI 0.60
  • ESLT 1.71
  • Stochastic Oscillator
  • ITCI 88.13
  • ESLT 96.46

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About ESLT Elbit Systems Ltd.

Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors world wide.

Share on Social Networks: